• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EGFR 表达与 clear cell renal cell carcinoma 中的骨桥蛋白和 Nf-κB 信号有关。

EGFR expression is linked to osteopontin and Nf-κB signaling in clear cell renal cell carcinoma.

机构信息

Department of Pathology, Rijeka University School of Medicine, Braće Branchetta 20, Rijeka, Croatia.

出版信息

Clin Transl Oncol. 2013 Jan;15(1):65-71. doi: 10.1007/s12094-012-0889-9. Epub 2012 Jul 24.

DOI:10.1007/s12094-012-0889-9
PMID:22855173
Abstract

AIM AND BACKGROUND

Epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase involved in many important aspects of cell biology that are related to tumorigenesis. There are opposite evidences of the role of EGFR in renal cancer and the outcome of EGFR-targeted therapies, suggesting the complexity of EGFR signaling pathways. In vitro, osteopontin (OPN) and nuclear factor kappa B (NF-κB) are thought to be involved in specific ligand-independent EGFR activation that could have a role in resistance to EGFR mAb therapy. Aim of this study was to analyze the relationship between EGFR and OPN at the protein and mRNA level, as well as their relation to NF-κB in clear cell renal cell carcinoma (CCRCC).

MATERIALS AND METHODS

Expression of EGFR, OPN, and p65 NF-κB protein was analyzed using immunohistochemistry and compared mutually in 88 CCRCC samples. Expression of EGFR and OPN mRNAs was analyzed using quantitative Real-time PCR in 22 CCRCC samples and compared mutually and with NF-κB protein expression.

RESULTS

Epidermal growth factor receptor mRNA level was higher in CCRCC samples in comparison with normal renal tissue (p = 0.012) and was associated with high OPN mRNA level, and with NF-κB activation (p < 0.001 and p = 0.045, respectively). Immunohistochemical staining showed the inverse association; high EGFR protein expression was related with low OPN and NF-κB protein expression (p < 0.001 and p = 0.047, respectively).

CONCLUSION

Epidermal growth factor receptor gene is upregulated in CRCC and associated with OPN gene expression and NF-kB signaling. The inverse relation between OPN and EGFR at the protein level could probably reflect dynamic changes that EGFR undergoes following activation.

摘要

目的和背景

表皮生长因子受体(EGFR)是一种受体酪氨酸激酶,参与与肿瘤发生相关的许多重要细胞生物学方面。EGFR 在肾癌中的作用及其 EGFR 靶向治疗的结果存在相反的证据,表明 EGFR 信号通路的复杂性。体外研究认为,骨桥蛋白(OPN)和核因子 kappa B(NF-κB)参与特定配体非依赖性 EGFR 激活,可能在 EGFR mAb 治疗耐药中发挥作用。本研究旨在分析在透明细胞肾细胞癌(CCRCC)中 EGFR 与 OPN 在蛋白和 mRNA 水平上的关系,以及它们与 NF-κB 的关系。

材料和方法

使用免疫组织化学分析 88 例 CCRCC 样本中 EGFR、OPN 和 p65 NF-κB 蛋白的表达,并相互比较。使用定量实时 PCR 分析 22 例 CCRCC 样本中 EGFR 和 OPN mRNA 的表达,并相互比较,同时与 NF-κB 蛋白表达进行比较。

结果

与正常肾组织相比,CCRCC 样本中 EGFR mRNA 水平更高(p=0.012),并与 OPN mRNA 水平升高和 NF-κB 激活相关(p<0.001 和 p=0.045)。免疫组织化学染色显示出相反的关联;高 EGFR 蛋白表达与低 OPN 和 NF-κB 蛋白表达相关(p<0.001 和 p=0.047)。

结论

CRCC 中 EGFR 基因上调,与 OPN 基因表达和 NF-kB 信号相关。OPN 和 EGFR 在蛋白水平上的反比关系可能反映了 EGFR 激活后发生的动态变化。

相似文献

1
EGFR expression is linked to osteopontin and Nf-κB signaling in clear cell renal cell carcinoma.EGFR 表达与 clear cell renal cell carcinoma 中的骨桥蛋白和 Nf-κB 信号有关。
Clin Transl Oncol. 2013 Jan;15(1):65-71. doi: 10.1007/s12094-012-0889-9. Epub 2012 Jul 24.
2
Osteopontin expression correlates with nuclear factor-κB activation and apoptosis downregulation in clear cell renal cell carcinoma.骨桥蛋白表达与核因子-κB 活化及肾透明细胞癌细胞凋亡下调相关。
Pathol Res Pract. 2011 Feb 15;207(2):104-10. doi: 10.1016/j.prp.2010.11.004. Epub 2010 Dec 16.
3
Relationship between vascular endothelial growth factor and nuclear factor-kappaB in renal cell tumors.肾细胞肿瘤中血管内皮生长因子与核因子-κB之间的关系
Croat Med J. 2008 Oct;49(5):608-17. doi: 10.3325/cmj.2008.5.608.
4
The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.YBX1 与 G3BP1 的相互作用通过 YBX1/G3BP1-SPP1-NF-κB 信号轴促进肾透明细胞癌细胞转移。
J Exp Clin Cancer Res. 2019 Sep 3;38(1):386. doi: 10.1186/s13046-019-1347-0.
5
NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues.核因子-κB表达与透明细胞肾细胞癌组织中的细胞凋亡和血管生成相关。
J Exp Clin Cancer Res. 2008 Oct 19;27(1):53. doi: 10.1186/1756-9966-27-53.
6
Upregulation of Rpn10 promotes tumor progression via activation of the NF-κB pathway in clear cell renal cell carcinoma.Rpn10 的上调通过激活 NF-κB 通路促进肾透明细胞癌的肿瘤进展。
Acta Biochim Biophys Sin (Shanghai). 2021 Jul 28;53(8):988-996. doi: 10.1093/abbs/gmab078.
7
Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression.免疫组织化学染色法检测肌纤维连接蛋白在透明细胞肾细胞癌中的预后意义及其与表皮生长因子受体表达的关系。
Urol Oncol. 2019 Nov;37(11):812.e9-812.e16. doi: 10.1016/j.urolonc.2019.07.002. Epub 2019 Aug 14.
8
Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-kappaB dependent AP-1-mediated ICAM-1 expression in breast cancer cells.骨桥蛋白选择性调节 p70S6K/mTOR 磷酸化,导致乳腺癌细胞中 NF-κB 依赖性 AP-1 介导的 ICAM-1 表达。
Mol Cancer. 2010 May 7;9:101. doi: 10.1186/1476-4598-9-101.
9
Recombinant osteopontin attenuates hyperoxia-induced acute lung injury through inhibiting nuclear factor kappa B and matrix metalloproteinases 2 and 9.重组骨桥蛋白通过抑制核因子κB以及基质金属蛋白酶2和9减轻高氧诱导的急性肺损伤。
Chin Med J (Engl). 2014;127(23):4025-30.
10
Meta-analysis identifies NF-κB as a therapeutic target in renal cancer.荟萃分析确定 NF-κB 为肾癌的治疗靶点。
PLoS One. 2013 Oct 7;8(10):e76746. doi: 10.1371/journal.pone.0076746. eCollection 2013.

引用本文的文献

1
Bisphenol AF Induces Prostatic Dorsal Lobe Hyperplasia in Rats through Activation of the NF-κB Signaling Pathway.双酚 AF 通过激活 NF-κB 信号通路诱导大鼠前列腺背侧叶增生。
Int J Mol Sci. 2023 Nov 12;24(22):16221. doi: 10.3390/ijms242216221.
2
The Intracellular and Secreted Sides of Osteopontin and Their Putative Physiopathological Roles.骨桥蛋白的细胞内和分泌面及其潜在的生理病理作用。
Int J Mol Sci. 2023 Feb 2;24(3):2942. doi: 10.3390/ijms24032942.
3
Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer.

本文引用的文献

1
Osteopontin expression correlates with nuclear factor-κB activation and apoptosis downregulation in clear cell renal cell carcinoma.骨桥蛋白表达与核因子-κB 活化及肾透明细胞癌细胞凋亡下调相关。
Pathol Res Pract. 2011 Feb 15;207(2):104-10. doi: 10.1016/j.prp.2010.11.004. Epub 2010 Dec 16.
2
Integrin signalling adaptors: not only figurants in the cancer story.整合素信号衔接蛋白:癌症故事中的不只是配角。
Nat Rev Cancer. 2010 Dec;10(12):858-70. doi: 10.1038/nrc2967. Epub 2010 Nov 24.
3
Understanding resistance to EGFR inhibitors-impact on future treatment strategies.
受体酪氨酸激酶及其信号通路作为姜黄素在癌症治疗中的靶点
Front Pharmacol. 2021 Nov 15;12:772510. doi: 10.3389/fphar.2021.772510. eCollection 2021.
4
Silencing Osteopontin Expression Inhibits Proliferation, Invasion and Induce Altered Protein Expression in Melanoma Cells.沉默骨桥蛋白表达抑制黑色素瘤细胞增殖、侵袭并诱导蛋白表达改变。
Pathol Oncol Res. 2021 Mar 5;27:581395. doi: 10.3389/pore.2021.581395. eCollection 2021.
5
Induction of Acquired Resistance towards EGFR Inhibitor Gefitinib in a Patient-Derived Xenograft Model of Non-Small Cell Lung Cancer and Subsequent Molecular Characterization.在非小细胞肺癌患者来源的异种移植模型中诱导对 EGFR 抑制剂吉非替尼的获得性耐药及后续的分子特征分析。
Cells. 2019 Jul 18;8(7):740. doi: 10.3390/cells8070740.
6
Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis.通过共表达分析鉴定人透明细胞肾细胞癌(ccRCC)中的关键基因和通路。
Int J Biol Sci. 2018 Feb 12;14(3):266-279. doi: 10.7150/ijbs.23574. eCollection 2018.
7
Crosstalk between VEGFR and other receptor tyrosine kinases for TKI therapy of metastatic renal cell carcinoma.VEGFR与其他受体酪氨酸激酶之间的相互作用在转移性肾细胞癌的TKI治疗中的研究
Cancer Cell Int. 2018 Mar 5;18:31. doi: 10.1186/s12935-018-0530-2. eCollection 2018.
8
Knockdown of NF-κB1 by shRNA Inhibits the Growth of Renal Cell Carcinoma In Vitro and In Vivo.短发夹 RNA 沉默 NF-κB1 抑制肾细胞癌细胞在体外和体内的生长。
Oncol Res. 2018 Jun 11;26(5):743-751. doi: 10.3727/096504017X15120379906339. Epub 2017 Dec 1.
9
Angiotensin 1-7, but not the thrombin-cleaved osteopontin C-terminal fragment, attenuates osteopontin-mediated macrophage-induced endothelial-cell inflammation.血管紧张素 1-7 而非凝血酶切割的骨桥蛋白 C 端片段可减轻骨桥蛋白介导的巨噬细胞诱导的内皮细胞炎症。
Inflamm Res. 2018 Mar;67(3):265-275. doi: 10.1007/s00011-017-1120-9. Epub 2017 Nov 27.
10
Sex difference in EGFR pathways in mouse kidney-potential impact on the immune system.小鼠肾脏中表皮生长因子受体(EGFR)信号通路的性别差异——对免疫系统的潜在影响
BMC Genet. 2016 Nov 24;17(1):146. doi: 10.1186/s12863-016-0449-3.
了解针对 EGFR 抑制剂的耐药性——对未来治疗策略的影响。
Nat Rev Clin Oncol. 2010 Sep;7(9):493-507. doi: 10.1038/nrclinonc.2010.97. Epub 2010 Jun 15.
4
Molecular detection of epidermal growth factor receptor in colorectal cancer: does it still make sense?结直肠癌中表皮生长因子受体的分子检测:是否仍有意义?
Colorectal Dis. 2011 May;13(5):542-8. doi: 10.1111/j.1463-1318.2010.02212.x.
5
Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinoma.描述人正常肾皮质和肾细胞癌中膜型和胞质型 EGFR 的表达。
J Biomed Sci. 2009 Sep 12;16(1):82. doi: 10.1186/1423-0127-16-82.
6
Interplay between cell adhesion and growth factor receptors: from the plasma membrane to the endosomes.细胞黏附与生长因子受体的相互作用:从质膜到内体。
Cell Tissue Res. 2010 Jan;339(1):111-20. doi: 10.1007/s00441-009-0857-z. Epub 2009 Sep 1.
7
Signal co-operation between integrins and other receptor systems.整合素与其他受体系统之间的信号协同作用。
Biochem J. 2009 Mar 15;418(3):491-506. doi: 10.1042/BJ20081948.
8
Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trial.拉帕替尼与激素疗法治疗晚期肾细胞癌患者的随机III期临床试验
J Clin Oncol. 2008 May 10;26(14):2285-91. doi: 10.1200/JCO.2007.14.5029.
9
Osteopontin: regulation in tumor metastasis.骨桥蛋白:肿瘤转移中的调控
Cancer Metastasis Rev. 2008 Mar;27(1):103-18. doi: 10.1007/s10555-007-9104-9.
10
EGFR inhibitor-mediated apoptosis in solid tumors.表皮生长因子受体抑制剂介导实体瘤中的细胞凋亡。
J Exp Ther Oncol. 2007;6(4):305-20.